%secondary_title%: The 200 Best Inventions of 2024

You May Be Interested In:Daniel Lurie Wins San Francisco Mayoral Race—Ousting London Breed


Detecting Alzheimer’s disease remains a challenge because its early symptoms can be subtle, but it’s becoming more critical as new treatments emerge. Often by the time symptoms of memory loss and cognitive decline appear, the degenerative brain condition is more difficult to treat. AlzPath developed the first commercial blood test for ptau217 in the blood, one of the early signs of neurodegeneration, that doctors can now order through specific labs to help identify patients sooner. It’s one of several tools doctors can utilize to improve diagnosis of patients, and in 2024, the company licensed its test to Roche to include in Roche’s diagnostic antibody-based testing platform. Roche then partnered with Eli Lilly to receive a Breakthrough Device designation by the FDA in June, which accelerates the development and review process for the blood test.

More Must-Reads from TIME

share Paylaş facebook pinterest whatsapp x print

Similar Content

How International Press Groups Are Reacting to Israel’s Labeling Six Gaza Journalists as  ‘Terrorists’
How International Press Groups Are Reacting to Israel’s Labeling Six Gaza Journalists as ‘Terrorists’
U.S. Stealth Bombers Target Underground Bunkers of Yemen's Houthi Rebels
U.S. Stealth Bombers Target Underground Bunkers of Yemen’s Houthi Rebels
The United States of Trial and Error
The United States of Trial and Error
Hundreds of Troops Kicked Out Under 'Don't Ask, Don't Tell' Get Upgraded to Honorable Discharges
Hundreds of Troops Kicked Out Under ‘Don’t Ask, Don’t Tell’ Get Upgraded to Honorable Discharges
Tropical Storm Trami Leaves at Least 24 Dead in Philippines
Tropical Storm Trami Leaves at Least 24 Dead in Philippines
Communities Try to Rebuild After Hurricane Helene and Milton
Communities Try to Rebuild After Hurricane Helene and Milton
News Sphere | © 2024 | News